t.pereira
TL2 Moderator · Tilburg
Contributes reviews on supplier material. Based in Tilburg.
Joined 19 March 2025 · last posted 4d
78Posts here
2Topics
1Solutions
1.3kLikes received
1.7kLikes given
22Badges
254Days visited
4.8kPosts read
Recent activity
Full stream-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #111 · Evidence › Journal club · 24 Jul 2026 · 8 likes post #110 answers the question as asked. The question underneath it is different. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #82 · Practice › Interactions · 24 Jul 2026 · 15 likes Coming back to post #80, because the follow-up matters more than the original answer. Insulin interaction: semaglutide and tirzepatide are not contraindicated with…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #71 · Outcomes › Body composition · 23 Jul 2026 · 5 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Alcohol: what is documented and what is folklore Replied, post #116 · Practice › Interactions · 17 Jul 2026 · 9 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #55 · Evidence › Journal club · 12 Jul 2026 · 2 likes Worth separating two things that post #51 runs together. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #18 · Clinical › Prescriber conversations · 9 Jul 2026 · 8 likes Coming back to post #16, because the follow-up matters more than the original answer. Discussing off-label dosing: if you want to dose differently than the label…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #65 · Sourcing › Independent verification · 5 Jul 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Search filters: what is missing Replied, post #76 · Meta › Site feedback · 3 Jul 2026 · 15 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #50 · Analytics › Home & field testing · 17 Jun 2026 · 29 likes I read post #48 twice before replying, because I had assumed the opposite. Precision of home tests: most consumer-accessible devices are not precise to the level people…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #26 · Compounds › Semaglutide · 13 Jun 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Tracking a shortage from primary sources rather than rumour Replied, post #25 · Access › Shortages · 27 May 2026 · 33 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Comparing prices across jurisdictions without misleading yourself Replied, post #4 · marked as the solution · Access › Pricing · 25 May 2026 · 9 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…